News > Sputnik V and AstraZeneca vaccine cocktail shows positive results in early trials

Sputnik V and AstraZeneca vaccine cocktail shows positive results in early trials

21/08/2021 05:27 PM | Click to read full article

A combination of the AstraZeneca vaccine and the first component of the Sputnik V vaccine(Sputnik Light) has shown high immunogenicity profile in a clinical study conducted in Azerbaijan.

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, AstraZeneca and R-Pharm have announced the preliminary results of immunogenicity of the combined use of the two vaccines. The heterogeneous boosting approach or ‘vaccine cocktail’ was at the core of Sputnik V, developed by Russia.